KO | Aksjer | 636,537 mrd. | — | KO KoAct | 0 | Helsevesen | | 3.8.2023 | 23 336,27 | 9,54 | 37,04 |
KO | Aksjer | 293,556 mrd. | — | KO KODEX | 0,45 | Helsevesen | FnGuide Bio Index - Benchmark TR Gross | 13.5.2016 | 13 140,85 | 7,35 | 37,93 |
TE | Aksjer | 290,568 mrd. | — | TE Tiger ETF | 0,40 | Helsevesen | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 6.10.2020 | 8 301,29 | 5,81 | 62,59 |
TE | Aksjer | 202,047 mrd. | — | TE Tiger ETF | 0,40 | Helsevesen | KRX Healthcare - KRW | 15.7.2011 | 50 817,26 | 5,63 | 47,81 |
TE | Aksjer | 104,964 mrd. | — | TE Tiger ETF | 0,30 | Helsevesen | NASDAQ / Biotechnology | 26.8.2014 | 31 350,97 | 5,08 | 22,19 |
KO | Aksjer | 96,449 mrd. | — | KO KODEX | 0,09 | Helsevesen | KRX Healthcare - KRW | 28.3.2017 | 22 975,75 | 5,63 | 47,83 |
TE | Aksjer | 95,142 mrd. | — | TE Tiger ETF | 0,40 | Helsevesen | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 14.12.2016 | 20 325,91 | 12,17 | 59,10 |
KR | Aksjer | 72,546 mrd. | — | KR KB RISE | 0 | Helsevesen | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 24.12.2024 | 17 668,54 | 9,56 | 68,04 |
KO | Aksjer | 63,182 mrd. | — | KO KODEX | 0,25 | Helsevesen | S&P Health Care Select Sector | 21.3.2023 | 13 695,71 | 5,11 | 23,89 |
TE | Aksjer | 62,455 mrd. | — | TE Tiger ETF | 0,49 | Helsevesen | Solactive China Biotech Index | 3.12.2020 | 8 266,30 | 3,99 | 35,92 |
TE | Aksjer | 47,316 mrd. | — | TE Tiger ETF | 0,45 | Helsevesen | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 29.2.2024 | 10 235,42 | 9,43 | 20,11 |
KO | Aksjer | 44,244 mrd. | — | KO KODEX | 0,45 | Helsevesen | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 14.2.2024 | 10 770,47 | 5,71 | 14,97 |
SP | Aksjer | 40,177 mrd. | 12,758 mill. | SP SPDR | 0,08 | Helsevesen | S&P Health Care Select Sector | 16.12.1998 | 152,89 | 5,20 | 24,21 |
TE | Aksjer | 32,539 mrd. | — | TE Tiger ETF | 0,40 | Helsevesen | KOSPI 200 Health Care Index - KRW | 23.9.2015 | 22 065,13 | 3,72 | 44,56 |
TE | Aksjer | 31,358 mrd. | — | TE Tiger ETF | 0 | Helsevesen | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 29.6.2016 | 25 908,41 | 0 | 0 |
HW | Aksjer | 28,041 mrd. | — | HW Hwabao | 0,60 | Helsevesen | CSI Medical Index Yield - Benchmark TR Gross | 20.5.2019 | 0,34 | 3,08 | 30,88 |
KO | Aksjer | 20,124 mrd. | — | KO KODEX | 0,25 | Helsevesen | S&P Biotechnology Select Industry | 31.10.2013 | 40 159,61 | 0 | 0 |
NH | Aksjer | 17,742 mrd. | — | NH NH-Amundi | 0 | Helsevesen | | 26.11.2024 | 16 568,54 | 6,27 | 44,18 |
EF | Aksjer | 17,641 mrd. | — | EF E Fund | 0 | Helsevesen | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 9.1.2021 | 0,37 | 3,40 | 26,67 |
VA | Aksjer | 16,921 mrd. | 259 153,6 | VA Vanguard | 0,09 | Helsevesen | MSCI US IMI 25/50 Health Care | 26.1.2004 | 282,72 | 5,01 | 23,10 |
KO | Aksjer | 14,362 mrd. | — | KO KoAct | 0,50 | Helsevesen | | 11.11.2025 | 10 280,58 | 5,63 | 23,60 |
KR | Aksjer | 11,679 mrd. | — | KR KB RISE | 0 | Helsevesen | FnGuide HealthCare Index - KRW - Benchmark TR Net | 23.9.2016 | 18 021,90 | 5,61 | 41,78 |
KI | Aksjer | 9,094 mrd. | — | KI Kiwoom | 0,49 | Helsevesen | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 28.5.2024 | 14 329,37 | 0 | 0 |
AC | Aksjer | 9,093 mrd. | — | AC ACE | 0,30 | Helsevesen | Solactive Global Big Pharma Index - Benchmark Price Return | 19.11.2024 | 12 922,48 | 7,56 | 22,90 |
KO | Aksjer | 8,874 mrd. | — | KO KODEX | 0 | Helsevesen | | 27.1.2026 | 9 342,76 | 3,99 | 29,08 |
AC | Aksjer | 8,594 mrd. | — | AC ACE | 0,45 | Helsevesen | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 19.11.2024 | 12 103,33 | 3,78 | 24,48 |
IS | Aksjer | 8,399 mrd. | 1,75 mill. | IS iShares | 0,44 | Helsevesen | NYSE Biotechnology (TR) | 5.2.2001 | 171,02 | 5,24 | 22,86 |
SP | Aksjer | 8,17 mrd. | 8,524 mill. | SP SPDR | 0,35 | Helsevesen | S&P Biotechnology Select Industry | 31.1.2006 | 126,42 | 5,04 | 0 |
TE | Aksjer | 6,472 mrd. | — | TE Tiger ETF | 0,50 | Helsevesen | FnGuide Medical Device Index - KRX - Benchmark TR Net | 7.11.2018 | 18 621,67 | 2,99 | 23,45 |
BO | Aksjer | 6,342 mrd. | — | BO Bosera | 0,65 | Helsevesen | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 18.3.2021 | 0,58 | 2,75 | 12,80 |
MA | Aksjer | 6,177 mrd. | — | MA Maxwealth | 0,60 | Helsevesen | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 22.4.2021 | 0,50 | 2,64 | 31,06 |
CH | Aksjer | 6,126 mrd. | — | CH ChinaAMC | 0,65 | Helsevesen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 29.9.2021 | 0,75 | 3,00 | 21,32 |
KI | Aksjer | 5,787 mrd. | — | KI Kiwoom | 0,49 | Helsevesen | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 28.5.2024 | 11 508,44 | 4,44 | 18,33 |
KO | Aksjer | 5,68 mrd. | — | KO KoAct | 0,50 | Helsevesen | | 3.9.2024 | 12 617,46 | 4,13 | 18,53 |
NI | Aksjer | 5,441 mrd. | — | NI Nippon | 0,19 | Helsevesen | Nifty Pharma Index - INR - Benchmark TR Gross | 2.7.2021 | 17,49 | 4,59 | 31,47 |
NF | Aksjer | 5,278 mrd. | — | NF NEXT FUNDS | 0,32 | Helsevesen | | 21.3.2008 | 32 216,48 | 1,89 | 20,85 |
KR | Aksjer | 5,247 mrd. | — | KR KB RISE | 0,35 | Helsevesen | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 27.2.2024 | 9 608,44 | 8,05 | 19,51 |
TE | Aksjer | 4,915 mrd. | — | TE Tiger ETF | 0,40 | Helsevesen | TOPIX-17 PHARMACEUTICAL - JPY | 29.6.2016 | 12 065,00 | 0 | 0 |
IC | Aksjer | 4,753 mrd. | — | IC ICBC | 0 | Helsevesen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 26.3.2025 | 1,25 | 0 | 0 |
IN | Aksjer | 4,108 mrd. | — | IN Invesco | 0 | Helsevesen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 16.10.2024 | 1,52 | 3,45 | 24,62 |
EF | Aksjer | 4,018 mrd. | — | EF E Fund | 0 | Helsevesen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 18.3.2025 | 1,18 | 0 | 0 |
IS | Aksjer | 3,806 mrd. | 293 937,6 | IS iShares | 0,40 | Helsevesen | S&P Global 1200 / Health Care -SEC | 13.11.2001 | 96,46 | 4,53 | 22,88 |
GU | Aksjer | 3,775 mrd. | — | GU Guotai | 0,60 | Helsevesen | CSI Biomedical Index - CNY - Benchmark TR Gross | 18.4.2019 | 0,96 | 0 | 0 |
XT | Aksjer | 3,422 mrd. | — | XT Xtrackers | 0,25 | Helsevesen | MSCI World Index / Health Care -SEC | 22.11.2010 | 57,66 | 4,75 | 23,33 |
IS | Aksjer | 3,378 mrd. | 1,913 mill. | IS iShares | 0,38 | Helsevesen | DJ US Select / Medical Equipment | 1.5.2006 | 56,27 | 4,15 | 32,44 |
IS | Aksjer | 3,022 mrd. | 719 638,1 | IS iShares | 0,38 | Helsevesen | Russell 1000 Health Care RIC 22.5/45 Capped Index | 12.6.2000 | 63,89 | 5,15 | 24,12 |
FU | Aksjer | 2,987 mrd. | — | FU Fullgoal | 0,60 | Helsevesen | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 14.6.2023 | 1,30 | 0 | 0 |
FI | Aksjer | 2,905 mrd. | 189 904,2 | FI Fidelity | 0,08 | Helsevesen | MSCI US IMI 25/50 Health Care | 21.10.2013 | 73,00 | 5,09 | 24,20 |
NH | Aksjer | 2,735 mrd. | — | NH NH-Amundi | 0,45 | Helsevesen | iSelect K-MediTech Index - KRW - Benchmark Price Return | 21.12.2023 | 9 115,65 | 3,43 | 26,31 |
IS | Aksjer | 2,661 mrd. | — | IS iShares | 0,15 | Helsevesen | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 20.11.2015 | 12,24 | 5,25 | 24,46 |
GU | Aksjer | 2,305 mrd. | — | GU Guotai | 0,60 | Helsevesen | CSI Medical Index Yield - Benchmark TR Gross | 24.12.2020 | 0,42 | 3,08 | 30,90 |
FT | Aksjer | 2,287 mrd. | 140 966,8 | FT First Trust | 0,54 | Helsevesen | NYSE Arca Biotechnology Index | 19.6.2006 | 199,34 | 3,40 | 22,79 |
HW | Aksjer | 2,266 mrd. | — | HW Hwabao | 0 | Helsevesen | Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross | — | 4,71 mrd. | 0 | 0 |
CH | Aksjer | 2,16 mrd. | — | CH ChinaAMC | 0,75 | Helsevesen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 14,37 | 3,50 | 28,15 |
CH | Aksjer | 2,132 mrd. | — | CH ChinaAMC | 0,75 | Helsevesen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 14,09 | 3,50 | 28,15 |
PA | Aksjer | 1,862 mrd. | — | PA Ping An | 0,60 | Helsevesen | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 9.6.2021 | 0,36 | 4,13 | 25,07 |
HE | Aksjer | 1,626 mrd. | — | HE Harvest ETFs | 1,06 | Helsevesen | | 19.11.2014 | 7,32 | 4,88 | 21,55 |
IS | Aksjer | 1,508 mrd. | — | IS iShares | 0,18 | Helsevesen | MSCI Europe Health Care 20/35 Capped Index - EUR | 17.11.2020 | 7,16 | 4,09 | 21,37 |
AM | Aksjer | 1,49 mrd. | — | AM Amundi | 0,50 | Helsevesen | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 8.6.2022 | 9 937,75 | 2,82 | 14,76 |
EF | Aksjer | 1,479 mrd. | — | EF E Fund | 0,20 | Helsevesen | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 19.1.2022 | 1,02 | 2,50 | 20,25 |
CA | Aksjer | 1,44 mrd. | — | CA Cathay | 1,05 | Helsevesen | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 22.11.2021 | 8,03 | 3,49 | 18,53 |
EF | Aksjer | 1,403 mrd. | — | EF E Fund | 0,20 | Helsevesen | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 14.1.2021 | 0,48 | 2,80 | 29,20 |
EF | Aksjer | 1,393 mrd. | — | EF E Fund | 0,20 | Helsevesen | China Securities Medical Index - CNY - Benchmark TR Gross | 8.7.2021 | 0,40 | 4,40 | 29,55 |
IS | Aksjer | 1,337 mrd. | — | IS iShares | 0,46 | Helsevesen | S&P Global 1200 Healthcare Sector Index - AUD | 13.11.2001 | 134,80 | 0 | 0 |
GU | Aksjer | 1,333 mrd. | — | GU Guotai | 0,60 | Helsevesen | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 1.8.2025 | 0,84 | 0 | 0 |
VA | Aksjer | 1,293 mrd. | 407 269,5 | VA VanEck | 0,36 | Helsevesen | MVIS US Listed Pharmaceutical 25 | 20.12.2011 | 106,05 | 5,28 | 20,03 |
EF | Aksjer | 1,216 mrd. | — | EF E Fund | 0,20 | Helsevesen | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 3.2.2021 | 0,64 | 3,14 | 28,62 |
XT | Aksjer | 1,157 mrd. | — | XT Xtrackers | 0,12 | Helsevesen | MSCI USA / Health Care -SEC | 12.9.2017 | 61,33 | 5,43 | 24,63 |
XT | Aksjer | 1,157 mrd. | — | XT Xtrackers | 0,12 | Helsevesen | MSCI USA / Health Care -SEC | 12.9.2017 | 61,33 | 5,43 | 24,63 |
IS | Aksjer | 1,036 mrd. | — | IS iShares | 0,40 | Helsevesen | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 8,83 | 4,07 | 22,24 |
HA | Aksjer | 1,035 mrd. | — | HA Harvest | 0,60 | Helsevesen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 30.7.2025 | 0,82 | 0 | 0 |
IS | Aksjer | 1,029 mrd. | — | IS iShares | 0,40 | Helsevesen | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 8,61 | 4,07 | 22,24 |
IS | Aksjer | 1,019 mrd. | 99 172,98 | IS iShares | 0,38 | Helsevesen | DJ US Select / Pharmaceutical | 1.5.2006 | 88,42 | 4,82 | 21,97 |
GX | Aksjer | 945,537 mill. | — | GX Global X | 0,59 | Helsevesen | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 21.6.2021 | 1 670,09 | 2,01 | 19,55 |
IS | Aksjer | 916,313 mill. | — | IS iShares | 0,35 | Helsevesen | NASDAQ / Biotechnology | 19.10.2017 | 8,60 | 0 | 0 |
FT | Aksjer | 875,51 mill. | 30 618,23 | FT First Trust | 0,61 | Helsevesen | StrataQuant Health Care Index | 8.5.2007 | 110,31 | 3,10 | 17,93 |
AM | Aksjer | 865,766 mill. | — | AM Amundi | 0,30 | Helsevesen | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 151,73 | 3,03 | 20,62 |
AM | Aksjer | 865,766 mill. | — | AM Amundi | 0,30 | Helsevesen | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 151,73 | 3,03 | 20,62 |
CS | Aksjer | 850,434 mill. | — | CS CSOP | 1,50 | Helsevesen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 21.7.2021 | 3,42 | 3,27 | 26,39 |
WA | Aksjer | 775,039 mill. | — | WA Wanjia | 0 | Helsevesen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 13.9.2024 | 1,47 | 3,45 | 24,62 |
AM | Aksjer | 755,907 mill. | — | AM Amundi | 0,30 | Helsevesen | MSCI World Index / Health Care -SEC | 19.8.2010 | 483,47 | 7,68 | 29,88 |
IN | Aksjer | 730,129 mill. | 94 989,37 | IN Invesco | 0,40 | Helsevesen | S&P 500 Equal Weighted / Health Care -SEC | 1.11.2006 | 31,35 | 3,30 | 21,11 |
IS | Aksjer | 720,251 mill. | — | IS iShares | 0,46 | Helsevesen | STOXX Europe 600 / Health Care (Capped) - SS | 25.4.2001 | 114,02 | 3,80 | 20,28 |
CA | Aksjer | 719,261 mill. | — | CA Cathay | 0,41 | Helsevesen | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 23.4.2019 | 29,95 | 0 | 0 |
PB | Aksjer | 718,658 mill. | 83 337,9 | PB Portfolio Building Block | 0,13 | Helsevesen | BITA Global Pharma and Biotech Select Index - Benchmark TR Net | 24.11.2025 | 25,97 | 5,48 | 21,33 |
IS | Aksjer | 699,206 mill. | 278 600 | IS iShares | 0,38 | Helsevesen | DJ US Select / Health Care Providers | 1.5.2006 | 44,14 | 2,29 | 17,03 |
SP | Aksjer | 634,15 mill. | — | SP SPDR | 0,30 | Helsevesen | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 29.4.2016 | 66,56 | 5,08 | 25,68 |
GX | Aksjer | 634,125 mill. | — | GX Global X | 0,68 | Helsevesen | Solactive China Biotech Index | 25.7.2019 | 68,10 | 4,17 | 39,20 |
GX | Aksjer | 626,51 mill. | — | GX Global X | 0,68 | Helsevesen | Solactive China Biotech Index | 25.7.2019 | 66,81 | 4,17 | 39,20 |
CS | Aksjer | 604,631 mill. | — | CS China Southern | 0,65 | Helsevesen | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 17.6.2022 | 1,08 | 2,98 | 21,35 |
IS | Aksjer | 602,289 mill. | — | IS iShares | 0,18 | Helsevesen | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 17.10.2019 | 7,64 | 4,16 | 22,04 |
SP | Aksjer | 591,965 mill. | — | SP SPDR | 0,18 | Helsevesen | MSCI Europe Health Care Index - EUR | 5.12.2014 | 227,17 | 4,01 | 20,91 |
SP | Aksjer | 572,362 mill. | — | SP SPDR | 0,15 | Helsevesen | S&P Health Care Select Sector Daily Capped 25/20 Index | 7.7.2015 | 47,21 | 5,20 | 24,21 |
IS | Aksjer | 539,741 mill. | — | IS iShares | 0,66 | Helsevesen | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 12.4.2011 | 69,50 | 0 | 0 |
CH | Aksjer | 529,292 mill. | — | CH ChinaAMC | 0,60 | Helsevesen | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 23.11.2023 | 0,87 | 2,64 | 31,04 |
FU | Aksjer | 527,046 mill. | — | FU Fullgoal | 0,60 | Helsevesen | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 16.3.2020 | 0,92 | 0 | 0 |
DI | Aksjer | 526,958 mill. | 580 253,1 | DI Direxion | 0,96 | Helsevesen | S&P Biotechnology Select Industry | 28.5.2015 | 167,17 | 0 | 0 |
GU | Aksjer | 479,196 mill. | — | GU Guotai | 0,60 | Helsevesen | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 8.9.2021 | 0,69 | 3,53 | 27,58 |
IN | Aksjer | 430,562 mill. | — | IN Invesco | 0,40 | Helsevesen | NASDAQ / Biotechnology | 6.11.2014 | 61,46 | 5,24 | 22,91 |
CS | Aksjer | 409,174 mill. | — | CS China Southern | 0,20 | Helsevesen | CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross | 12.3.2021 | 0,64 | 3,14 | 28,61 |